1. Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. (12th December 2022) Authors: Schumann, Katharina; Mauch, Cornelia; Klespe, Kai‐Christian; Loquai, Carmen; Nikfarjam, Ulrike; Schlaak, Max; Akçetin, Larissa; Kölblinger, Peter; Hoellwerth, Magdalena; Meissner, Markus; Mengi, Guelcin; Braun, Andreas Dominik; Mengoni, Miriam; Dummer, Reinhard; Mangana, Joanna; Sindrilaru, Mihae... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗